Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New HIV prevention strategy shows promise for At-Risk men in africa

NCT ID NCT02626286

Prevention Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a quarterly HIV prevention program is practical and helpful for men who have sex with men in four African countries. Over 800 men received regular check-ups, STI testing and treatment, counseling, and condoms. The goal was to see if this approach could lower HIV rates in this group and their partners.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
quarterly preventive care package (check-ups, STI treatment, counseling, condoms)
What this could lead to
If successful, this approach could help reduce HIV infections among men who have sex with men and their partners in sub-Saharan Africa.
What could go wrong
This is a feasibility study, not a large-scale trial. Results may not apply to other regions or populations, and the program's impact on HIV rates is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

885 people

The number who actually took part.

Started

Jun 2015

Finished

Jan 2021

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man over 18 years * Reporting at least one anal sex (passive or active) with another man within the last three months * Able to reach the local site of the study * Agreeing to participate in the study and signing the informed consent form Exclusion Criteria: * History of antiretroviral therapy (except for pre- or post-exposure prophylaxis) * Participation in another biomedical or behavioral research on HIV or sexually transmitted infections * Impairment of the person making his participation in the study, or information understanding, difficult or impossible * Predictable protocol violation (geographical distance or other reasons)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease Homosexuality

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV infection

Contacts and locations

Locations

  • Centre Oasis, Association African Solidarité (AAS)

    Ouagadougou, Burkina Faso

  • Clinique de Confiance, Espace Confiance

    Abidjan, Côte d’Ivoire

  • Clinique des Halles, ARCAD-SIDA

    Bamako, Mali

  • Espoir vie Togo

    Lomé, Togo

More trials for these conditions

Other studies related to the condition(s) this trial covers.